Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 31.16
+0.96 (3.18%)
Aug 21, 2026, 4:08 PM HKT
HKG:3378 Market Cap
HKG:3378 has a market cap or net worth of 4.24 billion as of August 21, 2026.
Market Cap
4.24B
Enterprise Value
3.64B
Revenue
102.38K
Ranking
n/a
PE Ratio
n/a
Stock Price
31.16
ChartMarket Cap Chart
Since December 23, 2025, HKG:3378's market cap has increased from 2.34B to 4.24B, an increase of 81.16%. That is a compound annual growth rate of 145.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 4.24B | 94.99% |
| Dec 31, 2025 | 2.18B | -7.09% |
| Dec 23, 2025 | 2.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 5.29B |
| Ocumension Therapeutics | 4.38B |
| TransThera Sciences (Nanjing) | 4.14B |
| Jacobio Pharmaceuticals Group | 4.06B |
| Qyuns Therapeutics | 3.93B |
| Mirxes Holding Company | 3.66B |
| Medtide | 3.30B |
| BioDlink International Company | 3.17B |